Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24

Trial Status

Completed3
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03829722Phase 2Completed
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
Oropharynx Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2019-09-05
NCT03416153Phase 2Completed
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
Oropharynx Cancer
PrincipalinvestigatorStart date: 2018-05-21
NCT02031250Phase 2Completed
Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
Squamous Cell Carcinoma of the Head and Neck
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jared Weiss, MD

University of North Carolina, Chapel Hill

Related
7 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCancer of Oropharnyx
Similarity Score15%

Charalampos Floudas, M.D.

National Cancer Institute (NCI)

Related
9 trials

Shared therapeutic areas:

Cancer of OropharnyxSquamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Douglas Adkins, M.D.

Washington University School of Medicine

Related
11 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckHead and Neck Neoplasms
Similarity Score15%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Cancer of OropharnyxSquamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Jian Zhang, Doctor

Fudan University

Related
7 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCancer of Oropharnyx
Similarity Score15%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Head and Neck Neoplasms
Similarity Score8%

Shivaani Kummar, M.D.

National Cancer Institute (NCI)

Related
9 trials

Shared therapeutic areas:

Head and Neck Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Xiaozhong Chen, MD

Zhejiang Cancer Hospital

Related
7 trials

Shared therapeutic areas:

Head and Neck Neoplasms
Similarity Score8%

Georges Paizis, MD

Sanofi

Related
7 trials

Shared therapeutic areas:

Head and Neck Neoplasms
Similarity Score8%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03829722Phase 2PrincipalInvestigator

Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer

Oropharynx Squamous Cell Carcinoma
Completed
NCT03416153Phase 2PrincipalInvestigator

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Oropharynx Cancer
Completed
NCT02031250Phase 2PrincipalInvestigator

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

Squamous Cell Carcinoma of the Head and Neck
Completed
NCT02485470Phase 2PrincipalInvestigator

Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy

Head and Neck Neoplasms
Terminated

All 4 trials loaded